ABSTRACT-The present study examined whether adenosine agonists influence the occurrence of giant migrating contractions (GMCs) induced by glycerol enema (65%, 2 ml/kg) in rats. Catheter pressure transducers were used to measure the colonic luminal manometric alterations. The adenosine A, agonists (2S)-N6-(2-endo-norbornyl)adenosine ((S)-ENBA) (10 pg/kg, i.v.) and N6-cyclohexyladenosine (30 pg/kg, i.v.) abolished the GMCs, whereas the adenosine A2 agonist 2-[p-(2-carboxyethyl)phenethylamino]-5"-N ethylcarboxamidoadenosine (CGS 21680) (30-300 pg/kg, i.v.) failed to influence the GMCs. The sup pressive action of (S)-ENBA on the GMCs was entirely counteracted by the peripheral adenosine antagonist 8-(p-sulfophenyl)theophylline (10 mg/kg, i.v.). The present observations suggest that the adenosine A, agonist suppresses the GMCs via peripheral adenosine receptors.
Colonic propagating contractions with high amplitude and long duration are referred to as giant migrating con tractions (GMCs), which have been reported to be closely associated with the provocation of urgency and defeca tion (1, 2). Glycerol enema, which is clinically used for the treatment of chronic constipation and for colonic lavage prior to colonoscopy procedures, has been known to elicit GMCs (3). We have previously reported that glycerol enema induced reproducible GMCs, which were abolished by hexamethonium, clonidine or lidocaine and were prominently inhibited by atropine, in anesthetized rats (4).
Recently, considerable interest has been focused on the physiological role of adenosine as an inhibitory neuro modulator. In view of the inhibitory action of adenosine on the release of principal excitatory neurotransmitters such as acetylcholine and tachykinins from enteric neuro nal synaptosomes (5, 6), it is expected that exogenously administered adenosine or adenosine agonists exert inhibitory effects on gastrointestinal motility. In fact, it was reported that adenosine inhibited vagally-stimulated gastric motility in rabbits (7), and that adenosine ago nists, by acting peripherally, suppressed the interdigestive migrating myoelectrical complex in the rat small intestine (8). As for the colon, Tonini et al. (9) described that ATP inhibited the propulsive contractions in the isolated rabbit colon. However, the in vivo effect of adenosine or adenosine agonists on colonic motility has not been re ported prior to the present study.
The purpose of this study was to clarify the effect of adenosine agonists on the occurrence of GMCs induced by glycerol enema in anesthetized rats. To discriminate the subtype of adenosine receptors involved, we employ ed the following selective adenosine agonists (10, 11): the potent adenosine A, agonist (2S)-N6-(2-endo-norbornyl) adenosine ((S)-ENBA), the less potent adenosine A, agonist N6-cyclohexyladenosine (CHA) and the adeno sine A2 agonist 2-[p-(2-carboxyethyl)phenethylamino]-5 N-ethylcarboxamidoadenosine (CGS 21680). The measurement and analysis of the colonic motor activity after glycerol enema were performed according to our previous method (4). Briefly, male Wistar strain rats (Charles River Japan, Inc., Atsugi), weighing 300-450 g and fasted overnight, were anesthetized with sodium pentobarbital (50 mg/kg, i.p.) and ketamine (10 mg/kg, i.p.). Three catheter pressure transducers (SPC-350, 5 French; Millar Instrument, Inc., Houston, TX, USA) were then inserted through the anus into the descending colon, so that the sensors of the catheters were positioned at the distance of 4 cm, 6 cm and 8 cm from the anal verge. Signals from the transducers were amplified through the control unit (TCB-500, Millar Instrument, Inc.) and recorded at the speed of 1 cm/min (Linearcord er WR-3701; Graphtec Corp., Tokyo). Forty minutes after the anesthesia, glycerol aqueous solution (65%, 2 ml/kg) prewarmed at 371C was infused over a 1-min period into the colon through a polyethylene tube (PE-50; Clay Adams, Parsippany, NJ, USA), whose tip was positioned at the distance of 7.5 cm from the anal verge. The adenosine agonist, (S)-ENBA (0.3 -10 pg/kg), CHA
(1-30 pg/kg) or CGS 21680 (30-300 pcg/kg), was admin istered (1 ml/kg, i.v.) 10 min before the glycerol enema. The adenosine antagonist 8-(p-sulfophenyl)theophylline (8-SPT) was administered (2 ml/kg, i.v.) 5 min before the glycerol enema. The intraperitoneal administration of the drug was carried out into the femoral vein.
To quantitatively evaluate the drug effect on glycerol-in duced manometric alterations, giant contractions (GCs) and GMCs were counted during 30 min from the begin ning of the glycerol enema: If the product of the ampli tude and duration of each wave was more than 1,000 mmHg • sec, the wave was regarded as a GC. When the total products of amplitude and duration of sequentially propagating waves over the 3 adjacent recording sites ex ceeded 3,000 mmHg • sec, the waves were interpreted as one GMC. Animals were used only once for the evalua tion. All the values were expressed as means±S.E.M., and a P value less than 0.05 was considered statistically significant.
(S)-ENBA, CHA, CGS 21680 hydrochloride and 8 SPT were purchased from Research Biochemicals Inter national (Natick, MA, USA); glycerol was from Kanto Chemical (Tokyo). CHA and CGS 21680 were dissolved in saline; 8-SPT was dissolved in distilled water. (S) ENBA was dissolved in dimethylsulfoxide (DMSO) (10 mg/ml) and then diluted with saline. The solvent DMSO, whose final concentration was 0.1 % or lower, had no effect on the glycerol-induced manometric alterations in the preliminary experiment.
A representative tracing of the manometric alterations induced by glycerol enema (65%, 2 ml/kg) is shown in Fig. 1A , in which conspicuous GCs and GMCs were ob served. The occurrence of GCs and GMCs was abolished by (S)-ENBA (10 pg/kg, i.v.) (Fig. 1B) or CHA (30 pg/kg, i.v.) (Fig. 1C) , but was not substantially influenced by CGS 21680 (300 pg/kg, i.v.) (Fig. 1D) . In terestingly, in the tracing shown in Fig. 1 B, spontaneous ly occurring GCs were by chance observed at 4 cm prior to the glycerol enema. These GCs were also abolished by (S)-ENBA. Another interesting event is that CGS 21680 (300 pg/kg, i.v.) per se elicited manometric alterations, which were not so intense as those induced by glycerol en ema (Fig. 1D) . Since the stimulation of adenosine A2 recep tors on the smooth muscle cells causes relaxation of the rat colon strip (12), we suspect that CGS 21680 elicited the manometric alterations not by directly acting on the smooth muscle cells, but perhaps by acting on the enteric neurons. (1-30 pg/kg, i.v.) unequivocally and dose-dependently decreased the numbers of GCs and GMCs. In contrast, CGS 21680 (30-300 pg/kg) did not exhibit any sig nificant difference in the numbers of GCs or GMCs in comparison with those in the saline-treated control. The suppressive action of (S)-ENBA, which has higher affinity to adenosine A, receptors than CHA (10), was more prominent than that of CHA. Thus, it is suggested that the suppression of GCs and GMCs is associated with the stimulation of adenosine A, receptors. The slight suppres sive action of CGS 21680 is likely to be ascribed to the low er affinity of this drug to adenosine A, receptors (11).
In the next experiment, we employed the adenosine an tagonist 8-SPT to investigate the possible involvement of adenosine receptors in the suppressive action of (S) ENBA on the occurrence of GCs and GMCs. Table 1 shows the numbers of GCs and GMCs occurring during 30 min from the beginning of glycerol enema (65%, 2 ml/kg) in rats, which were pretreated with (S)-ENBA (10 pg/kg) or its vehicle (0.107o DMSO) followed by 8-SPT (10 mg/kg) or its vehicle (distilled water). The conspicu ous GCs and GMCs occurred in rats treated with vehicles only, whereas no GC or GMC was observed in rats treat ed with (S)-ENBA and vehicle. However, there was no statistical difference in the numbers of GCs and GMCs be tween the group treated with vehicles only and the group treated with (S)-ENBA and 8-SPT, indicating that the sup pressive action of (S)-ENBA was completely counteracted by 8-SPT. These observations suggest that adenosine A, agonists suppress the occurrence of GCs and GMCs via adenosine receptors. The responsible receptors probably exist peripherally because 8-SPT is a polar adenosine an tagonist, which hardly crosses the blood brain barrier (13).
It is known that adenosine inhibits the release of bio synthetically-labeled ['HIacetylcholine from the syn aptosomal fraction of guinea pig ileal myenteric plexus (5). Assuming that the similar reduction of acetylcholine re lease is elicited in the rat colon as well as in the guinea pig ileum, this reduced release of acetylcholine might be in volved in the suppressive action of adenosine A, agonists. This interpretation coincides with our previous finding (4) that the principal neuronal pathway involved in the occur rence of GCs and GMCs in rats is cholinergic. Since the stimulation of adenosine A, receptors on the smooth mus cle cells causes contraction of the smooth muscle prepara tion of rat colon (14), the direct action of adenosine A, agonists on the smooth muscle cells is unlikely to contrib ute to the suppression of GCs and GMCs.
In regard to the pathological significance of GMCs in colonic diseases, Karaus and Sarna (1), by observing GMCs in dogs, framed the hypothesis that too frequent occurrence of GMCs may result in rapid propulsion and diarrhea. This hypothesis was afterward substantiated in a clinical study, in which the increase in the number of GMCs was demonstrated in patients with functional diar rhea (2). Considering this clinical observation, the present study suggests the possibility that adenosine A, agonists could inhibit diarrhea in patients with conspicuous GMCs. Indeed, Tucker et al. (15) previously found that the adenosine Al agonist CHA suppressed morphine withdrawal diarrhea in mice. Likewise, we observed that the adenosine agonist (S)-ENBA suppressed diarrhea provoked by 16,16-dimethylprostaglandin E2 in rats (A. Tomaru et al., unpublished data) . However, clinical use of adenosine A, agonists as anti-diarrheal drugs may be limited because of the well-known adverse cardiovascular reactions induced by these compounds including negative cardiac inotropy, chronotropy and dromotropy. Table 1 . Effects of (S)-ENBA (10 pg/kg, i.v.) and/or 8-(p-sulfo phenyl)theophylline (8-SPT) (10 mg/kg, i.v.) on the numbers of giant contractions (GCs) and giant migrating contractions (GMCs) observed during 30 min from the beginning of glycerol enema (65010, 2 ml/kg) in rats
